Archit Organosys Ltd
Archit Organosys Ltd (ARCHITORG) last traded at ₹63, a market capitalisation of ₹129 crore, on a P/E of 323. Over the past 52 weeks the stock has ranged between ₹34 and ₹65.3. Archit Organosys Ltd last reported results for the quarter ended Mar 2024, with sales of ₹30.99 crore and net profit of ₹1.79 crore. Figures are as of 25 Aug 2026 and are not real time.
Archit Organosys Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Archit Organosys Ltd quarterly results
In the quarter ended Mar 2024, sales were ₹30.99 cr, down 33.4% from ₹46.55 cr a year earlier. Net profit was ₹1.79 cr, down 7.7% year on year.
| ₹ crore | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 30.35 | 28.46 | 22.42 | 46.55 | 31 | 26.39 | 24.81 | 30.99 |
| Expenses | 23.18 | 23.22 | 18.84 | 43.64 | 27.75 | 24.28 | 23.71 | 31.16 |
| Operating profit | 7.17 | 5.24 | 3.58 | 2.91 | 3.25 | 2.11 | 1.1 | -0.17 |
| OPM % | 23.62% | 18.41% | 15.97% | 6.25% | 10.48% | 8.00% | 4.43% | -0.55% |
| Other income | 0.21 | 0.16 | 1.84 | 1.29 | 0.64 | 0.54 | 0.52 | 4.11 |
| Interest | 0.86 | 0.32 | 0.52 | 0.51 | 0.52 | 0.65 | 0.77 | 0.64 |
| Depreciation | 1.2 | 1.17 | 1.31 | 1.16 | 1.19 | 1.49 | 1.49 | 1.02 |
| Profit before tax | 5.32 | 3.91 | 3.59 | 2.53 | 2.18 | 0.51 | -0.64 | 2.28 |
| Tax % | 22.56% | 21.74% | 37.88% | 23.32% | 27.52% | 27.45% | -29.69% | 21.49% |
| Net profit | 4.12 | 3.06 | 2.23 | 1.94 | 1.57 | 0.37 | -0.46 | 1.79 |
| EPS (₹) | 2.01 | 1.49 | 1.09 | 0.95 | 0.77 | 0.18 | -0.22 | 0.87 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Archit Organosys Ltd annual results
| ₹ crore | Mar 2007 | Mar 2008 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|
| Sales | 19 | 21 | 138 | 128 | 113 |
| Operating profit | 1 | 1 | 17 | 20 | 7 |
| OPM % | 3.6% | 4.1% | 12% | 15% | 6% |
| Net profit | 0 | 0 | 8 | 11 | 3 |
| EPS (₹) | 0.39 | 0.41 | 4.01 | 5.53 | 1.60 |
TTM is the trailing twelve months to the most recent quarter.
Archit Organosys Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -11%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -96%
- 10 Years
- 15%
- 5 Years
- 9%
- 3 Years
- 4%
- 1 Year
- 36%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 11%
- Last Year
- 1%
Archit Organosys Ltd shareholding pattern
Promoters held 65.88% at Jun 2026, broadly unchanged since Jun 2025.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 64.65% | 64.84% | 65.30% | 65.39% | 65.39% | 65.86% | 65.88% | 65.88% |
| Public | 35.35% | 35.15% | 34.70% | 34.61% | 34.60% | 34.15% | 34.12% | 34.11% |
| No. of shareholders | 10,389 | 10,198 | 9,972 | 9,947 | 9,847 | 9,630 | 9,446 | 8,959 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Archit Organosys Ltd corporate filings
- Newspaper Publication of Unaudited Financial Results for the Quarter ended on 30th June, 2026.Company Updatelow impact
Cruxal's analysis: Archit Organosys Limited has released its unaudited financial results for the quarter…
Read the full analysis - Approval of Unaudited Financial Result for the Quarter ended on 30th June, 2026Board Meetingmedium impact
Cruxal's analysis: Archit Organosys Limited reported revenue from operations of 37.08 crore for the quarter…
Read the full analysis - Archit Organosys Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....Board Meetinglow impact
Cruxal's analysis: Archit Organosys Limited has formally intimated the BSE regarding a Board of Directors…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Archit Organosys Ltd
Cruxal reads every Archit Organosys Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.